Vinge has advised Terranor Group AB (publ) (“Terranor”) connection with its listing on Nasdaq First North Growth Market. The first day of trading in Terranor's shares is today 30 June 2025.

The offering price was SEK 20 per share, corresponding to a total market value for all shares in Terranor of SEK 400 million. The total value of the offering amounts to SEK 115 million, provided that the overallotment option is exercised in full.

Terranor is one of the leading players in road maintenance in the Nordic region. The company’s business concept is to offer a wide range of qualified services in road operation and maintenance to ensure that roads remain accessible and functional all year round. The business covers both winter road maintenance, with snow removal and anti-slip protection, and summer maintenance, such as repairs and asphalt work. In addition, Terranor offers services in green area management, road safety and light infrastructure projects.

Vinge’s team primarily consisted of David Andersson, Joel Magnusson, Anna Svensson, Karin Karsten, Johannes Akyol, Sara Franson and Elias Kröger (Capital Markets), Jonas Bergström and Fredrik Eriksson Oppliger (M&A), Hanna Lemne and Julia Rydin (EU, Competition and Regulatory), Calle Tengwall Pagels and Katja Häglund (Financing), Mario Saad, Carla Håkansson, Sara Link and Filippa Eriksson (Commercial agreements, IT and GDPR), Niclas Lindblom (Construction Law), Alice Göransson (Labor Law), Hayaat Ibrahim (Compliance), Hanna Kövamees (Real Estate Law) and Melinda Oldenburg (IP).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026